Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
2 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Podocalyxin variants and risk of prostate cancer and tumor aggressiveness.
Hum Mol Genet. 2006 Mar 1;15(5):735-41. doi: 10.1093/hmg/ddi487. Epub 2006 Jan 24.
Hum Mol Genet. 2006.
PMID: 16434482
The 76-gene signature defines high-risk patients that benefit from adjuvant tamoxifen therapy.
Zhang Y, Sieuwerts AM, McGreevy M, Casey G, Cufer T, Paradiso A, Harbeck N, Span PN, Hicks DG, Crowe J, Tubbs RR, Budd GT, Lyons J, Sweep FC, Schmitt M, Schittulli F, Golouh R, Talantov D, Wang Y, Foekens JA.
Zhang Y, et al.
Breast Cancer Res Treat. 2009 Jul;116(2):303-9. doi: 10.1007/s10549-008-0183-2. Epub 2008 Sep 23.
Breast Cancer Res Treat. 2009.
PMID: 18821012
Clinical Trial.
Item in Clipboard
Cite
Cite